Clinical Trials Data Magazine 
Freedom Leaf
JULY 20, 2017
Researchers noted that, for many factors, the data showed “an initial decrease in values but [then an] eventual increase.” Recent clinical trials data also find that the administration of specific cannabinoids, such as CBD and THC-V, are positively associated with reductions in blood pressure and blood sugar levels.
Freedom Leaf
JANUARY 10, 2018
“We’re actively working toward developing new genetics to work on efficacy and assist the patients in Israel still operating with our nurse-run clinics in order to better provide the right dosage and strains for the patients who are referred to us by the Ministry of Health,” Stephen Gardner, Tikun Olam’s chief marketing officer, tells Freedom Leaf.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Weedistry
MARCH 11, 2019
That sentiment is shared by upstarts including Cannuka, a line of topical products containing CBD and manuka honey; Khus & Khus, a skin- and body-care line by the ayurvedic specialist Kristi Blustein; and Vertly, a line of lip balm by Claudia Mata, a former W magazine accessories editor, which is introducing body care this year.
Cannabis Law Report
NOVEMBER 24, 2021
At the same time, the outlook on cannabis research data is largely positive. Our research focuses on discourse about cannabis in several major medical journals and magazines for Australian doctors. Data collection. One coder then independently coded the entire dataset and entered the data into NVivo v12.
Cannabis Law Report
JULY 21, 2022
Patient safety concerns uncovered during an ongoing federal review have led to the suspension of one of two clinical trials for MDMA-assisted psychotherapy currently underway in Canada. ” The complaint alleges that MAPS improperly blended data from small study sites that used different methodologies to produce favourable results.
Cannabis Law Report
JUNE 4, 2021
Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Shelby Hartman is the Co-founder and Editor-in-Chief of Double Blind Mag, a newly launched magazine on psychedelics. James Keim.
Expert insights. Personalized for you.
43 
Let's personalize your content